Meet the most despised man in the world: Outrage as ex-hedge funder buys rights to AIDS drug and promptly raises price overnight - from $13.50 to $750.00 per pill

Martin Shkreli, 32, founder and chief executive of Turing Pharmaceuticals, purchased the rights to Daraprim which is used for treating life-threatening parasitic infections - for $55million. He raised the price of the drug form $13.50 per tablet to $750 per tablet. Since the announcement, people across social media have criticized the price increase, but Shkreli has backed the decision, saying that his company 'needed to turn a profit on the drug'.